Literature DB >> 181908

The expression of the syn- gene of herpes simplex virus type 1. II. Requirements for macromolecular synthesis.

J M Keller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181908     DOI: 10.1016/0042-6822(76)90169-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

1.  Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins.

Authors:  R Manservigi; P G Spear; A Buchan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production.

Authors:  L I Pizer; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

3.  Syncytium formation caused by human cytomegalovirus in human embryonic lung fibroblasts.

Authors:  J C Booth; J E Beesley; H Stern
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  Timing of some of the molecular events required for cell fusion induced by herpes simplex virus type 1.

Authors:  K G Kousoulas; S Person; T C Holland
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

5.  Characterization of an herpes simplex virus type 2 mutant, which is resistant to acycloguanosine and causes fusion of BSC1 cells.

Authors:  E Katz; E Margalith
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus.

Authors:  S Chatterjee; J Bradac; E Hunter
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

7.  Alterations of neutral glycolipids in cells infected with syncytium-producing mutants of herpes simplex virus type 1.

Authors:  M A Ruhlig; S Person
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

8.  Characteristics of cell fusion induced by a caprine retrovirus.

Authors:  T M Ellis; G E Wilcox; W F Robinson
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.